NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses

T Watanabe, A Kitani, PJ Murray, W Strober - Nature immunology, 2004 - nature.com
T Watanabe, A Kitani, PJ Murray, W Strober
Nature immunology, 2004nature.com
The mechanism by which mutations in CARD15, which encodes nucleotide-binding
oligomerization domain 2 (NOD2), cause Crohn disease is poorly understood. Because
signaling via mutated NOD2 proteins leads to defective activation of the transcription factor
NF-κB, one proposal is that mutations cause deficient NF-κB-dependent T helper type 1
(TH1) responses and increased susceptibility to infection. However, this idea is inconsistent
with the increased TH1 responses characteristic of Crohn disease. Here we used Card15 …
Abstract
The mechanism by which mutations in CARD15, which encodes nucleotide-binding oligomerization domain 2 (NOD2), cause Crohn disease is poorly understood. Because signaling via mutated NOD2 proteins leads to defective activation of the transcription factor NF-κB, one proposal is that mutations cause deficient NF-κB-dependent T helper type 1 (TH1) responses and increased susceptibility to infection. However, this idea is inconsistent with the increased TH1 responses characteristic of Crohn disease. Here we used Card15−/− mice to show that intact NOD2 signaling inhibited Toll-like receptor 2–driven activation of NF-κB, particularly of the NF-κB subunit c-Rel. Moreover, NOD2 deficiency or the presence of a Crohn disease–like Card15 mutation increased Toll-like receptor 2–mediated activation of NF-κB–c-Rel, and TH1 responses were enhanced. Thus, CARD15 mutations may lead to disease by causing excessive TH1 responses.
nature.com